- Merck acquired Acceleron Pharma, a company developing drugs to treat cardiovascular and other blood-related disorders, for about $11.5 billion.
- Pfizer is acquiring Arena Pharmaceuticals, a company developing potential treatments for immuno-inflammatory diseases, for about $6.7 billion.
- AmerisourceBergen acquired Alliance Healthcare, Walgreens Boots Alliance’s wholesaling arm, for $6.5 billion.
- PerkinElmer bought antibody and reagents maker BioLegend for $5.25 billion.
- Sanofi acquired clinical-stage mRNA therapeutics company Translate Bio for about $3.2 billion.
- Pfizer acquired Canadian cancer drugmaker Trillium Therapeutics for $2.26 billion.
- Sanofi acquired drugmaker Kadmon for $1.9 billion.
- Amgen acquired cancer drugmaker Five Prime Therapeutics for about $1.9 billion.
- Merck acquired Pandion Therapeutics, a drugmaker specializing in autoimmune disease treatments, for $1.85 billion.
- Roche acquired GenMark Diagnostics, a company that produces molecular tests that can identify the presence of several different pathogens, for $1.8 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
